| Changing the FDA Approval Process | February 02, 2011 |
Susan Desmond-Hellmann
|
UCSF |
Entrepreneurial Thought Leaders Lecture Series |
| Views: 659 |
|
| Video 7 of 10 from this talk |
- 56:10Relentless Pursuit of Innovation [Entire Talk]
- 06:37Early Path of a Biotech Innovator
- 04:37A Story of Biotech Innovation
- 03:13Innovation in Academics
- 02:17Balancing Risk Against Reward
- 01:25Rewarding Team Achievement
- 03:22Changing the FDA Approval Process
- 01:44Innovating Health Sciences to Reduce Cost
- 03:26Qualities of Risk Taking Entrepreneurs
- 01:36Keeping Your Internal Compass
Description
Susan Desmond-Hellmann, chancellor of UCSF, has a big idea to change the drug approval process at the Food and Drug Administration (FDA). The current process is binary, allowing for only a yes or no from the reviewer for drug approval. Desmond-Hellmann suggests that a variable approval process, that can change status as greater evidence comes in over time, will encourage more innovative products and even investment funding, based on product confidence.
Comments 
Related Videos:
